Published on : Jul 28, 2016
ALBANY, New York, July 28, 2016: ResearchMoz.us has added a new report, titled “Global Rheumatoid Arthritis Market Report: 2016 Edition,” to its offering. This report presents a detailed analysis on the market for rheumatoid arthritis and provides highlights on all the major factors impacting the development of this market. For the compilation of this report, various industry experts have been interviewed. The prime trends in the market, the key industry-relevant news, and the issues experienced by the established vendors have also been presented through this study.
The first section of the report provides an overview of the rheumatoid arthritis market. This section also provides information on the major symptoms associated with this type of arthritis and its prime treatment options. In general terms, arthritis is the inflammation of a joint and can be of many types such as degenerative arthritis, infectious, metabolic, and inflammation arthritis. Rheumatoid arthritis falls under the category of inflammatory arthritis and is a chronic autoimmune disease.
The disease takes place in 4 key stages and is diagnosed by utilizing imaging tests, medical history, and certain kinds of blood tests. As of now, there has been no cure found for rheumatoid arthritis, however, a number of treatments are available for the management of this type of arthritis in order to reduce pain. These include surgery, physical exercise, and drugs.
Click here to get more info with TOC in a PDF Format: http://www.researchmoz.us/enquiry.php?type=S&repid=746067
The next section of the report presents the major factors impacting the development of the global rheumatoid arthritis market. The increasing demand for effective drugs and enhanced medical facilities will boost the growth of the market. In addition, the increasing aging population will also provide impetus to the development of this market as the aging population is more prone to arthritis. Furthermore, the rising female population, the growing obese population, and the rising cigarette consumption will also positively impact the development of the global rheumatoid arthritis market.
The increasing approval for RA drugs from the FDA, the growing competition from anti-IL6 drugs, the rising share of biosimilars, and the growing employment of alternative and complementary medicine are the chief trends seen in the market, as per this study. On the other hand, the increasing cost of research and development and the soaring costs of treatment may inhibit the development of this market in the coming years.
In the next section of the study, the geographical segmentation of the market has been presented. Geographically, the U.S rheumatoid arthritis market currently leads owing to the significant number of patients of rheumatoid arthritis present in the U.S. At the end of the report, the competitive landscape of the market has been presented. This section presents highlights on the prime players dominant in the global rheumatoid market and their key contributions in the market. The key players are Abbott Diagnostics (Abbott Laboratories), Beckman Coulter, Inc., Antibodies Inc., Euro Diagnostica AB, Antibodies Inc., F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH., Qiagen NV., and Thermo Fisher Scientific Inc., among others.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org